Search result for "alnylam"
Approximately 9 trademarks found.
ALNYLAM
Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), hereditary ATTR...
Current Owner: Alnylam Pharmaceuticals, Inc.
Status: REGISTERED
Filed on: 2018-05-18
ALNYLAM
SCIENTIFIC RESEARCH, SCIENTIFIC RESEARCH IN THE FIELDS OF PHARMACEUTICALS AND MEDICINE, CHEMICAL AND MEDICAL LABORATORIES
Current Owner: Alnylam Pharmaceuticals Inc.
Status: REGISTERED AND RENEWED
Filed on: 2002-07-19
ALNYLAM BIOTHERAPEUTICS
a full line of pharmaceuticals, biosimilars and biological preparations for medical purposes
Current Owner: Alnylam Pharmaceuticals, Inc.
Status: ABANDONED - NO STATEMENT OF USE FILED
Filed on: 2010-05-07
ALNYLAM ACT
DNA screening for scientific research purposes; DNA screening for forensic research purposes; DNA screening for genetic mutations for scientific...
Current Owner: Alnylam Pharmaceuticals, Inc.
Status: REGISTERED
Filed on: 2017-02-17
A ALNYLAM BIOTHERAPEUTICS
a full line of pharmaceuticals, biosimilars and biological preparations for medical purposes
Current Owner: Alnylam Pharmaceuticals, Inc.
Status: ABANDONED - NO STATEMENT OF USE FILED
Filed on: 2010-05-07
ALNYLAM ASSIST
DNA screening for scientific research purposes; DNA screening for forensic research purposes; DNA screening for genetic mutations for scientific...
Current Owner: Alnylam Pharmaceuticals, Inc.
Status: ABANDONED - NO STATEMENT OF USE FILED
Filed on: 2014-10-17
ALNYLAM ASSIST
Providing information on financial assistance programs; reimbursement payment processing services in the field of health care
Current Owner: Alnylam Pharmaceuticals, Inc.
Status: REGISTERED
Filed on: 2018-02-23
ALNYLAM ASSIST
Providing information on financial assistance programs for the access of pharmaceutical treatments and therapies; reimbursement payment processing...
Current Owner: Alnylam Pharmaceuticals, Inc.
Status: REGISTERED
Filed on: 2022-01-26
ALNYLAMACT
DNA screening for scientific research purposes; DNA screening for forensic research purposes; DNA screening for genetic mutations for scientific...
Current Owner: Alnylam Pharmaceuticals, Inc.
Status: REGISTERED
Filed on: 2017-02-17
